XML 32 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue
9 Months Ended
Sep. 30, 2020
Revenue from Contract with Customer [Abstract]  
REVENUE

14. REVENUE

 

We primarily offer the First Defense® product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the nine-month period ended September 30, 2020 or the year ended December 31, 2019. We do not have any contract assets for which we have satisfied the performance obligations but do not yet have the right to bill for or contract liabilities such as customer advances. All trade receivables on our balance sheets are from contracts with customers. We incur no material costs to obtain contracts.

 

The following table presents our product sales disaggregated by geographic area:

 

   During the Three-Month
Periods Ended
September 30,
   During the Nine-Month
Periods Ended
September 30,
 
   2020   2019   2020   2019 
United States  $3,361,820   $2,728,368   $10,319,232   $9,033,592 
Other(1)   360,679    242,128    1,279,626    1,057,385 
Total product sales  $3,722,517   $2,970,496   $11,598,858   $10,090,977 

 

(1)Sales outside of the United States included $133,601 of non-animal health sales during the first quarter of 2019, which product has since been divested.

 

The following table presents our product sales disaggregated by major product category:

 

   During the Three-Month
Periods Ended
September 30,
   During the Nine-Month
Periods Ended
September 30,
 
   2020   2019   2020   2019 
First Defense® product line  $3,656,709   $2,873,732   $11,406,481   $9,687,181 
Other animal health   65,808    96,764    192,377    270,195 
Other               133,601 
Total product sales  $3,722,517   $2,970,496   $11,598,858   $10,090,977